These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus. Akbay E; Yetkin I; Ersoy R; Kulaksizoğlu S; Törüner F; Arslan M Diabetes Nutr Metab; 2004 Dec; 17(6):331-5. PubMed ID: 15887626 [TBL] [Abstract][Full Text] [Related]
3. [Serum lipids and diabetic control with special reference to angiopathy (author's transl)]. Morimoto M Rinsho Byori; 1975 Jan; 23(1):1-6. PubMed ID: 1168267 [No Abstract] [Full Text] [Related]
4. [Significance of hexosamines in the development of angiopathies in patients with diabetes mellitus]. Spesivtseva VG; Starosel'tseva LK; Frenkel' VKh; Mamaeva GG; Mikhaĭlova NA Sov Med; 1972 Mar; 35(3):49-52. PubMed ID: 5018174 [No Abstract] [Full Text] [Related]
5. [Behavior of the glycoproteins in the blood serum in diabetes mellitus]. Laskowski S Przegl Lek; 1966; 22(8):521-5. PubMed ID: 5954884 [No Abstract] [Full Text] [Related]
6. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy]. Sánchez Martín S; García Díez LC; García Marcos MA; Miralles García JM Rev Clin Esp; 1983 May; 169(3):189-90. PubMed ID: 6612032 [No Abstract] [Full Text] [Related]
7. [Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. Di Cesare E; Quartarone M; Cucinotta D; Coglitore G; Squadrito G Minerva Med; 1979 May; 70(22):1601-3. PubMed ID: 88025 [No Abstract] [Full Text] [Related]
8. [Content of PAS-positive substances in the lymphocytes in diabetes mellitus and angiopathies]. Lapko LI; Gruzov MA Vrach Delo; 1980 Apr; (4):83-5. PubMed ID: 7385781 [No Abstract] [Full Text] [Related]
9. Management of hyperlipidemia in diabetes. Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431 [No Abstract] [Full Text] [Related]
10. [Erythrocyte fatty acids of patients with diabetes mellitus and diabetic microangiopathies]. Naumenko VG; Ganich VG; Bagleĭ EA; Efimov AS; Sidorak EP Klin Med (Mosk); 1985 Mar; 63(3):91-6. PubMed ID: 3999683 [No Abstract] [Full Text] [Related]
11. [Status of the blood kallikrein-kinin system in diabetes mellitus]. Bezverkhaia TP; Sakhno TA Vrach Delo; 1982 Sep; (9):31-3. PubMed ID: 6924809 [No Abstract] [Full Text] [Related]
12. [Postheparinic lipolytic activity in diabetes]. Plamieniak L Pol Tyg Lek; 1974 Jul; 29(28):1197-200. PubMed ID: 4846887 [No Abstract] [Full Text] [Related]
13. [Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease]. Bodnar PN; Donish RM; Buglak NI; Panasiukova OR Ter Arkh; 1983; 55(12):78-81. PubMed ID: 6665725 [No Abstract] [Full Text] [Related]
14. [Mobilization of intracellular Ca2+ by ADP and thrombin in platelets of patients with diabetes mellitus with vascular complications]. Kubatiev AA; Balashova TS; Rud'ko IA; Tomilova EN Biull Eksp Biol Med; 1996 Jan; 121(1):112-5. PubMed ID: 8679990 [No Abstract] [Full Text] [Related]
16. [Lipids and diabetic macroangiopathy: role of HDL]. Fuller JH; Salter A; Mattock MB Journ Annu Diabetol Hotel Dieu; 1982; ():203-10. PubMed ID: 7098248 [No Abstract] [Full Text] [Related]
17. [The nature of hyperglycemia in diabetes mellitus]. Kamysheva EP; Danilova MI; Sorochkina RM Klin Med (Mosk); 1983 Feb; 61(2):52-5. PubMed ID: 6843058 [No Abstract] [Full Text] [Related]
18. Microangiopathy with special reference to conjugated proteins in subjects with latent chemical diabetes. Bhu N; Kachawa ID; Sarin LR J Assoc Physicians India; 1968 Nov; 16(11):809-16. PubMed ID: 5728676 [No Abstract] [Full Text] [Related]
19. The significance of vascular complications, blood lipid alterations and I-131-lipid tolerance test in diabetes mellitus. Banerjee RN; Chakravarty B; Gupta SR Indian J Med Res; 1969 Jun; 57(6):1105-14. PubMed ID: 5823178 [No Abstract] [Full Text] [Related]